Stereotaxis (OTCMKTS:STXS) posted its quarterly earnings data on Tuesday, March 6th. The medical equipment provider reported ($0.01) earnings per share (EPS) for the quarter, Morningstar.com reports. The firm had revenue of $7.56 million for the quarter. Stereotaxis had a negative return on equity of 5.60% and a negative net margin of 18.90%.
Shares of Stereotaxis stock opened at $0.67 on Thursday. Stereotaxis has a fifty-two week low of $0.48 and a fifty-two week high of $1.10. The company has a market cap of $15.96, a PE ratio of -1.90 and a beta of 3.31.
Stereotaxis Company Profile
Stereotaxis, Inc is a United States-based healthcare technology company. The Company is engaged in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease. The Company also provides information management solutions for the interventional lab.
Receive News & Ratings for Stereotaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stereotaxis and related companies with MarketBeat.com's FREE daily email newsletter.